Skip to content

Cogent Biosciences, Inc. COGT Tax on Share Settlement

Tax on Share Settlement at other companies

Incyte logo
IncyteINCY
$6.96M-26.4%
CG Oncology logo
CG OncologyCGON
$174K
Exelixis logo
ExelixisEXEL
$34.23M+52.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.07M+129%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$103.6M+54.2%
Biogen logo
BiogenBIIB
$55.1M+127%

Other financials

Income statement

See full
Operating income-$103.6M-38.3%
Net income-$97.4M-35.2%
EPS (diluted)-$0.53-1.9%

Balance sheet

See full
Cash & equivalents$241.2M+91.4%
Total debt$15.5M-9.4%
Total equity$607.7M+177%
Total assets$903.0M+218%

Cash flow

See full
Operating cash flow-$86.9M-30.6%
CapEx$449.0K-17.9%
Free cash flow-$87.3M-30.2%

Valuation

See full
Market cap$5.9B+816%
Enterprise value$5.68B+951%
P/S749.8×

Profitability

See full
Operating margin-1,044.3%
Net margin-950.4%
FCF margin-184.7%

Returns & leverage

See full
Return on equity-85.7%+1.7pp
Debt / equity-0.1×
Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Cogent Biosciences, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s tax on share settlement?
Cogent Biosciences, Inc. (COGT) reported tax on share settlement of $12.22M in Q4 2025.
What does tax on share settlement mean?
Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.